Keywords: teva, 4th-qtr, profits, up, eps, falls, short

Teva's 4th-qtr profits up 42%, but EPS falls short

Article | 19 February 2007

Print This

Israeli generic drugmaker Teva Pharmaceuticals says that, for the quarter ended December 31, its net income was $433.0 million, up 42% on the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in